Cancer and Molecular Biomarkers of Phase 2
Authors:
- Kaspar Buus JensenKJKaspar Buus Jensen
- Henrik Enghusen PoulsenHPHenrik Enghusen Poulsen
- 1 January 2005
- book chapter
- Published by Elsevier
- Vol. 400, 618-627
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Polymorphisms in Steroid Hormone Pathway Genes and Mammographic DensityBreast Cancer Research and Treatment, 2003
- Phenol sulphotransferase SULT1A1*1 genotype is associated with reduced risk of colorectal cancerPharmacogenetics, 2001
- Sulfation pharmacogenetics:SULT1A1 and SULT1A2 allele frequencies in Caucasian, Chinese and African-American subjectsPharmacogenetics, 2001
- Proteases for Cell Suicide: Functions and Regulation of CaspasesMicrobiology and Molecular Biology Reviews, 2000
- Sulfotransferases in the bioactivation of xenobioticsChemico-Biological Interactions, 2000
- Sulfation of aromatic hydroxamic acids and hydroxylamines by multiple forms of human liver sulfotransferasesCarcinogenesis, 1994
- Polymorphisms for aromatic amine metabolism in humans: relevance for human carcinogenesis.Environmental Health Perspectives, 1992
- The UDP Glucuronosyltransferase Gene Super family: Suggested Nomenclature Based on Evolutionary DivergenceDNA and Cell Biology, 1991
- Human Arylamine N -Acetyltransferase Genes: Isolation, Chromosomal Localization, and Functional ExpressionDNA and Cell Biology, 1990
- ROLE OF N-ACETYLTRANSFERASE PHENOTYPES IN BLADDER CARCINOGENESIS: A PHARMACOGENETIC EPIDEMIOLOGICAL APPROACH TO BLADDER CANCERThe Lancet, 1982